These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 8286097)
1. Induction of oxidative burst response in human neutrophils by immune complexes made in vitro of lipopolysaccharide and hyperimmune serum from chronically infected patients. Kronborg G; Fomsgaard A; Jensen ET; Kharazmi A; Høiby N APMIS; 1993 Nov; 101(11):887-94. PubMed ID: 8286097 [TBL] [Abstract][Full Text] [Related]
2. Lipopolysaccharide (LPS), LPS-immune complexes and cytokines as inducers of pulmonary inflammation in patients with cystic fibrosis and chronic Pseudomonas aeruginosa lung infection. Kronborg G APMIS Suppl; 1995; 50():1-30. PubMed ID: 7756034 [TBL] [Abstract][Full Text] [Related]
3. Nonopsonic antibodies in cystic fibrosis. Pseudomonas aeruginosa lipopolysaccharide-specific immunoglobulin G antibodies from infected patient sera inhibit neutrophil oxidative responses. Eichler I; Joris L; Hsu YP; Van Wye J; Bram R; Moss R J Clin Invest; 1989 Dec; 84(6):1794-804. PubMed ID: 2512330 [TBL] [Abstract][Full Text] [Related]
4. Enhancement of lipopolysaccharide-induced tumor necrosis factor secretion by hyperimmune serum from chronic infected patients. Kronborg G; Fomsgaard A; Høiby N Med Microbiol Immunol; 1993 Dec; 182(6):305-16. PubMed ID: 8121331 [TBL] [Abstract][Full Text] [Related]
5. Association of systemic immune complexes, complement activation, and antibodies to Pseudomonas aeruginosa lipopolysaccharide and exotoxin A with mortality in cystic fibrosis. Moss RB; Hsu YP; Lewiston NJ; Curd JG; Milgrom H; Hart S; Dyer B; Larrick JW Am Rev Respir Dis; 1986 Apr; 133(4):648-52. PubMed ID: 3083745 [TBL] [Abstract][Full Text] [Related]
6. Effects of ginseng treatment on neutrophil chemiluminescence and immunoglobulin G subclasses in a rat model of chronic Pseudomonas aeruginosa pneumonia. Song Z; Kharazmi A; Wu H; Faber V; Moser C; Krogh HK; Rygaard J; Hoiby N Clin Diagn Lab Immunol; 1998 Nov; 5(6):882-7. PubMed ID: 9801351 [TBL] [Abstract][Full Text] [Related]
7. The immunoglobulin G subclass composition of immune complexes in cystic fibrosis. Implications for the pathogenesis of the Pseudomonas lung lesion. Hornick DB; Fick RB J Clin Invest; 1990 Oct; 86(4):1285-92. PubMed ID: 2120286 [TBL] [Abstract][Full Text] [Related]
8. NET formation induced by Pseudomonas aeruginosa cystic fibrosis isolates measured as release of myeloperoxidase-DNA and neutrophil elastase-DNA complexes. Yoo DG; Floyd M; Winn M; Moskowitz SM; Rada B Immunol Lett; 2014 Aug; 160(2):186-94. PubMed ID: 24670966 [TBL] [Abstract][Full Text] [Related]
9. Effect of high-affinity anti-Pseudomonas aeruginosa lipopolysaccharide antibodies induced by immunization on the rate of Pseudomonas aeruginosa infection in patients with cystic fibrosis. Lang AB; Schaad UB; Rüdeberg A; Wedgwood J; Que JU; Fürer E; Cryz SJ J Pediatr; 1995 Nov; 127(5):711-7. PubMed ID: 7472821 [TBL] [Abstract][Full Text] [Related]
10. An easy microtiter assay for quantitation of cytokine induction by lipopolysaccharide (LPS) and activity of LPS-binding serum components. Garde AH; Fomsgaard A; Høiby N APMIS; 1995 Apr; 103(4):286-92. PubMed ID: 7612259 [TBL] [Abstract][Full Text] [Related]
11. Immune complexes from immunized mice and infected cystic fibrosis patients mediate murine and human T cell killing of hybridomas producing protective, opsonic antibody to Pseudomonas aeruginosa. Pier GB; Takeda S; Grout M; Markham RB J Clin Invest; 1993 Mar; 91(3):1079-87. PubMed ID: 8450038 [TBL] [Abstract][Full Text] [Related]
12. Antibody responses to lipid A, core, and O sugars of the Pseudomonas aeruginosa lipopolysaccharide in chronically infected cystic fibrosis patients. Kronborg G; Fomsgaard A; Galanos C; Freudenberg MA; Høiby N J Clin Microbiol; 1992 Jul; 30(7):1848-55. PubMed ID: 1378455 [TBL] [Abstract][Full Text] [Related]
13. Anti-LPS IgA and IgG Can Inhibit Serum Killing of Pseudomonas aeruginosa in Patients with Cystic Fibrosis. Pham A; Ledger EL; Coggon CF; Henderson IR; Reid DW; Bell SC; Smith DJ; Wells TJ Infect Immun; 2021 Nov; 89(12):e0041221. PubMed ID: 34460286 [TBL] [Abstract][Full Text] [Related]
14. Antibodies from chronically infected cystic fibrosis patients react with lipopolysaccharides extracted by new micromethods from all serotypes of Pseudomonas aeruginosa. Fomsgaard A; Shand GH; Freudenberg MA; Galanos C; Conrad RS; Kronborg G; Høiby N APMIS; 1993 Feb; 101(2):101-12. PubMed ID: 7683890 [TBL] [Abstract][Full Text] [Related]
15. Opsonization of mucoid and non-mucoid Pseudomonas aeruginosa by serum from patients with cystic fibrosis assessed by a chemiluminescence assay. LeBlanc CM; Bortolussi R; Issekutz AC; Gillespie T Clin Invest Med; 1982; 5(2-3):125-8. PubMed ID: 6811181 [TBL] [Abstract][Full Text] [Related]